Allan Jordan

Dr. Allan Jordan

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SRStephen D. Roughley
Stephen D. Roughley
AJAllan Jordan
Allan Jordan

20 November 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPaul A. Brough
Paul A. Brough
WAWynne Aherne
Wynne Aherne
XBXavier Barril
Xavier Barril
JBJenifer Borgognoni
Jenifer Borgognoni
KBKathy Boxall
Kathy Boxall
LWLisa Wright
Lisa Wright

27 September 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
MPMelissa B. Pappalardi
Melissa B. Pappalardi
KKKathryn Keenan
Kathryn Keenan
MCMark Cockerill
Mark Cockerill
WKWendy A. Kellner
Wendy A. Kellner
ASAlexandra Stowell
Alexandra Stowell
MMMichael T. McCabe
Michael T. McCabe

17 July 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PBPaul A. Brough
Paul A. Brough
XBXavier Barril
Xavier Barril
JBJenifer Borgognoni
Jenifer Borgognoni
PCPatrick Chene
Patrick Chene
NDNicholas G. M. Davies
Nicholas G. M. Davies
LWLisa Wright
Lisa Wright

1 December 2013 in Drug Discovery Today
Verified
Journal Article
Closed access
AMAndrew D. Morley
Andrew D. Morley
APAngelo Pugliese
Angelo Pugliese
KBKristian Birchall
Kristian Birchall
JBJustin Bower
Justin Bower
PBPaul Brennan
Paul Brennan
PWPaul G. Wyatt
Paul G. Wyatt

12 October 2016 in ACS Chemical Biology
Verified
Journal Article
Open access
DJDominic I. James
Dominic I. James
KSKate M. Smith
Kate M. Smith
AJAllan Jordan
Allan Jordan
EFEmma E. Fairweather
Emma E. Fairweather
LGLouise A. Griffiths
Louise A. Griffiths
DODonald J. Ogilvie
Donald J. Ogilvie
The enzyme poly(ADP-ribose) glycohydrolase (PARG) performs a critical role in the repair of DNA single strand breaks (SSBs). However, a detailed understanding of its mechanism of action has been hampered by a lack of credible, cell-active chemical probes. Herein, we demonstrate inhibition of PARG with a small molecule, leading to poly(ADP-ribose) (PAR) chain persistence in intact cells. Moreover, we describe two advanced, and chemically distinct, cell-active tool compounds with convincing on-target pharmacology and selectivity. Using one of these tool compounds, we demonstrate pharmacology consistent with PARG inhibition. Further, while the roles of PARG and poly(ADP-ribose) polymerase (PARP) are closely intertwined, we demonstrate that the pharmacology of a PARG inhibitor differs from that observed with the more thoroughly studied PARP inhibitor olaparib. We believe that these tools will facilitate a wider understanding of this important component of DNA repair and may enable the development of novel therapeutic agents exploiting the critical dependence of tumors on the DNA damage response (DDR).